Arkolith/Insider Trading/PLRX/Form 4

Cummings Keith Lamont

Chief Financial OfficerPLIANT THERAPEUTICS, INC. (PLRX) · full profile →Form 4 · filed Jul 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$126K
Net Open-Market Flow
-$126K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2024Sell(S)11K$11.56$126K282K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001746473-24-000125) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML